Evidence map›Paper›PMID 42697575›Full record

ArticleBMJ open2026

Infection prevention and control measures during the COVID-19 pandemic in sub-Saharan Africa: a multinational cross-sectional study.

Lena Böff, Kouassi Julien Momou, Jean Florent Rafamatanantsoa, Francis Mosala, Felix Reichert, Idesbald Boone, Sounan Fidèle Touré, Pati Pyana, Lantonirina Ravaoarisoa, Sagesse Nduenga and 19 more

Abstract readMulticenter Study
In one paragraph

Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Lena Böff *Robert Koch Institute, Berlin, Germany boeffl@rki.de.ORCID 0009-0008-5356-7971
Kouassi Julien Momou *Centre Hospitalier et Universitaire de Bouaké, Bouaké, Côte d'Ivoire.ORCID 0000-0002-6943-1509
Jean Florent Rafamatanantsoa *Laboratoire d'Analyses Médicales Malagasy, Antananarivo, Madagascar.
Francis MosalaInstitut National de Recherche Biomédicale, Kinshasa, Congo (the Democratic Republic of the).
Felix ReichertRobert Koch Institute, Berlin, Germany.
Idesbald BooneRobert Koch Institute, Berlin, Germany.
Sounan Fidèle TouréCentre Hospitalier et Universitaire de Bouaké, Bouaké, Côte d'Ivoire.ORCID 0009-0000-8726-0822
Pati PyanaInstitut National de Recherche Biomédicale, Kinshasa, Congo (the Democratic Republic of the).
Lantonirina RavaoarisoaLaboratoire d'Analyses Médicales Malagasy, Antananarivo, Madagascar.ORCID 0000-0002-9237-9120
Sagesse NduengaInstitut National de Recherche Biomédicale, Kinshasa, Congo (the Democratic Republic of the).
Anna-Lisa BehnkeRobert Koch Institute, Berlin, Germany.ORCID 0000-0002-8118-7051
Andele ConradieRobert Koch Institute, Berlin, Germany.
Khaled FerchichiRobert Koch Institute, Berlin, Germany.ORCID 0009-0008-4953-2434
Marek FuchsPrivate Consultant, Darmstadt, Germany.ORCID 0000-0003-1262-0664
Sophie MüllerRobert Koch Institute, Berlin, Germany.ORCID 0000-0001-7723-3943
Chinwe Lucia OchuNigeria Centre for Disease Control and Prevention, Abuja, Nigeria.ORCID 0000-0002-0630-7332
Giuseppina OrtuPrivate Consultant, London, UK.
Francisco Pozo-MartinRobert Koch Institute, Berlin, Germany.
Angela SchusterRobert Koch Institute, Berlin, Germany.
Ann Christin VietorRobert Koch Institute, Berlin, Germany.
Sabrina WeissRobert Koch Institute, Berlin, Germany.ORCID 0000-0002-4835-3695
Tim EckmannsRobert Koch Institute, Berlin, Germany.
Bamourou DianéCentre Hospitalier et Universitaire de Bouaké, Bouaké, Côte d'Ivoire.
Steve AhukaInstitut National de Recherche Biomédicale, Kinshasa, Congo (the Democratic Republic of the).
Zely RandriamanantanyLaboratoire d'Analyses Médicales Malagasy, Antananarivo, Madagascar.
Chantal Akoua-KoffiCentre Hospitalier et Universitaire de Bouaké, Bouaké, Côte d'Ivoire.
Sara TomczykRobert Koch Institute, Berlin, Germany.ORCID 0000-0001-6975-2663
Tochi OkworNigeria Centre for Disease Control and Prevention, Abuja, Nigeria.ORCID 0000-0003-2391-7770
Charbel El BcheraouiRobert Koch Institute, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo assess the implementation of infection prevention and control (IPC) measures and associated factors in healthcare in low-resource settings during the COVID-19 pandemic.

designMultinational cross-sectional study.

settingThe study was conducted from February to November 2022 in Côte d'Ivoire, Democratic Republic of Congo, Madagascar and Nigeria.

participantsA total of 6749 healthcare workers (HCWs) at 324 healthcare facilities (HCFs) were enrolled from different levels of care and types. PRIMARY AND SECONDARY OUTCOMES: Standardised HCW and HCF questionnaires assessed COVID-19-related exposures and IPC measures and descriptive analyses were conducted overall and by country and HCF. Partial proportional odds models were used to assess factors associated with HCW compliance to hand hygiene and mask wearing.

resultsAmong 324 HCFs, the reported presence of IPC programmes ranged from 51.4% (n=111) at primary non-hospitals to 83.3% (n=18) at tertiary HCFs. More than half reported no patient or HCW screening (57.4%, n=186). Only 19.8% (n=64) reported handrub at point of care in every room. Among 6749 enrolled HCWs, 54.0% were working in high-risk patient care. More HCWs reported sufficient availability of masks (62.7%, n=4231) compared with respirators (28.5%, n=1926). HCW compliance with hand hygiene and mask wearing, respectively, was improved by presence of an IPC programme (OR: 1.3, 95% CI 1.2 to 1.5; OR: 1.4, 95% CI 1.2 to 1.6), IPC training received by the HCW (OR: 1.5, 95% CI 1.3 to 1.7; OR: 1.3, 95% CI 1.2 to 1.5) and availability of handrub and masks, respectively (OR: 5.9, 95% CI 4.1 to 8.4; OR: 2.3, 95% CI 2.0 to 2.7).

conclusionsWe conducted a large survey including HCFs across levels of care and type in urban and rural regions in sub-Saharan Africa. Critical gaps in IPC programmes and access to IPC equipment during the COVID-19 pandemic hindered HCW compliance with recommended IPC practices. To improve general infection control and pandemic preparedness in low-resource settings, continued focus on strengthening IPC programmes and ensuring access to materials/equipment is essential.

Indexed as

COVID-19Health PersonnelInfection ControlAdultAfrica South of the SaharaCross-Sectional StudiesFemaleGuideline AdherenceHand HygieneHumansMaleMasksPandemicsResource-Limited SettingsSARS-CoV-2Surveys and QuestionnairesAfrica South of the SaharaCOVID-19Delivery of Health Care, IntegratedHealth ServicesINFECTIOUS DISEASES

Identifiers

PMID42697575
PMCPMC13548276

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.